| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |